Clinical Trials List
Protocol Number1438-0011
Not yet recruiting
2026-05-01 - 2030-12-31
Phase III
Recruiting2
-
Trial Applicant
Boehringer Ingelheim
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 姜乃榕 無
- San-Chi Chen 無
- 唐振育 無
- Yi-Ping Hung 無
- 邱乃祈 無
Co-Principal Investigator
- Chien-Jui Huang 無
- Yung-Yeh Su 無
- 廖亭凱 無
- 劉奕廷 無
- Chih-Chieh Yen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jen-Shi Chen 無
- Po-Jung Su 無
- Wen-Chi Chou 無
- Ming-Mo Hou 無
- 賴盈傑 無
- Yung-Chia Kao 無
- Chia-Hsun Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
390 participants
